Regular exercise has multi-system anti-aging effects. Here we summarize how exercise impacts the major hallmarks of aging. We propose that, besides searching for novel pharmaceutical targets of the aging process, more research efforts should be devoted to gaining insights into the molecular mediators of the benefits of exercise and to implement effective exercise interventions for elderly people.
Get full access to this article
View all access options for this article.
References
1.
GarberCE, BlissmerB, DeschenesMR, FranklinBA, LamonteMJ, LeeIM, NiemanDC, SwainDP, American College of Sports M. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: Guidance for prescribing exercise. Med Sci Sports Exerc, 2011; 43:1334–1359.
2.
HollenbergM, YangJ, HaightTJ, TagerIB. Longitudinal changes in aerobic capacity: Implications for concepts of aging. J Gerontol A Biol Sci Med Sci, 2006; 61:851–858.
3.
StathokostasL, Jacob-JohnsonS, PetrellaRJ, PatersonDH. Longitudinal changes in aerobic power in older men and women. J Appl Physiol, 2004; 97:781–789.
4.
FlegJL, MorrellCH, BosAG, BrantLJ, TalbotLA, WrightJG, LakattaEG. Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation, 2005; 112:674–682.
5.
ShephardRJ. Maximal oxygen intake and independence in old age. Br J Sports Med, 2009; 43:342–346.
6.
HagbergJM, AllenWK, SealsDR, HurleyBF, EhsaniAA, HolloszyJO. A hemodynamic comparison of young and older endurance athletes during exercise. J Appl Physiol, 1985; 58:2041–2046.
7.
OgawaT, SpinaRJ, MartinWH3rd, KohrtWM, SchechtmanKB, HolloszyJO, EhsaniAA. Effects of aging, sex, and physical training on cardiovascular responses to exercise. Circulation, 1992; 86:494–503.
8.
StrattonJR, LevyWC, CerqueiraMD, SchwartzRS, AbrassIB. Cardiovascular responses to exercise. Effects of aging and exercise training in healthy men. Circulation, 1994; 89:1648–1655.
9.
HawkinsSA, MarcellTJ, Victoria JaqueS, WiswellRA. A longitudinal assessment of change in VO2max and maximal heart rate in master athletes. Med Sci Sports Exerc, 2001; 33:1744–1750.
10.
EskurzaI, DonatoAJ, MoreauKL, SealsDR, TanakaH. Changes in maximal aerobic capacity with age in endurance-trained women: 7-yr follow-up. J Appl Physiol, 2002; 92:2303–2308.
11.
HossackKF, BruceRA. Maximal cardiac function in sedentary normal men and women: Comparison of age-related changes. J Appl Physiol, 1982; 53:799–804.
12.
RiveraAM, PelsAE3rd, SadySP, SadyMA, CullinaneEM, ThompsonPD. Physiological factors associated with the lower maximal oxygen consumption of master runners. J Appl Physiol, 1989; 66:949–954.
13.
WiebeCG, GledhillN, JamnikVK, FergusonS. Exercise cardiac function in young through elderly endurance trained women. Med Sci Sports Exerc, 1999; 31:684–691.
14.
ProctorDN, JoynerMJ. Skeletal muscle mass and the reduction of VO2max in trained older subjects. J Appl Physiol, 1997; 82:1411–1415.
15.
TothMJ, GardnerAW, AdesPA, PoehlmanET. Contribution of body composition and physical activity to age-related decline in peak VO2 in men and women. J Appl Physiol, 1994; 77:647–652.
16.
LakattaEG, LevyD. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: Aging arteries: a “set up” for vascular disease. Circulation, 2003; 107:139–146.
17.
CogganAR, SpinaRJ, KingDS, RogersMA, BrownM, NemethPM, HolloszyJO. Histochemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women. J Gerontol, 1992; 47:B71–B76.
18.
SchrageWG, EisenachJH, JoynerMJ. Ageing reduces nitric-oxide- and prostaglandin-mediated vasodilatation in exercising humans. J Physiol, 2007; 579:227–236.
19.
DegensH. Age-related changes in the microcirculation of skeletal muscle. Adv Exp Med Biol, 1998; 454:343–348.
20.
ConleyKE, JubriasSA, EsselmanPC. Oxidative capacity and ageing in human muscle. J Physiol, 2000; 526(Pt 1):203–210.
21.
JanssenI, HeymsfieldSB, WangZM, RossR. Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr. J Appl Physiol., 2000; 89:81–88.
22.
LexellJ, TaylorCC, SjostromM. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci, 1988; 84:275–294.
23.
SainiA, FaulknerS, Al-ShantiN, StewartC. Powerful signals for weak muscles. Ageing Res Rev, 2009; 8:251–267.
24.
FronteraWR, HughesVA, FieldingRA, FiataroneMA, EvansWJ, RoubenoffR. Aging of skeletal muscle: A 12-yr longitudinal study. J Appl Physiol, 2000; 88:1321–1326.
Cruz-JentoftAJ, BaeyensJP, BauerJM, BoirieY, CederholmT, LandiF, MartinFC, MichelJP, RollandY, SchneiderSM, TopinkovaE, VandewoudeM, ZamboniM. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 2010; 39:412–423.
27.
MuscaritoliM, AnkerSD, ArgilesJ, AversaZ, BauerJM, BioloG, BoirieY, BosaeusI, CederholmT, CostelliP, FearonKC, LavianoA, MaggioM, Rossi FanelliF, SchneiderSM, ScholsA, SieberCC. Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.”. Clin Nutr, 2010; 29:154–159.
28.
FieldingRA, VellasB, EvansWJ, BhasinS, MorleyJE, NewmanAB, Abellan van KanG, AndrieuS, BauerJ, BreuilleD, CederholmT, ChandlerJ, De MeynardC, DoniniL, HarrisT, KanntA, Keime GuibertF, OnderG, PapanicolaouD, RollandY, RooksD, SieberC, SouhamiE, VerlaanS, ZamboniM. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc, 2011; 12:249–256.
29.
MorleyJE, AbbatecolaAM, ArgilesJM, BaracosV, BauerJ, BhasinS, CederholmT, CoatsAJ, CummingsSR, EvansWJ, FearonK, FerrucciL, FieldingRA, GuralnikJM, HarrisTB, InuiA, Kalantar-ZadehK, KirwanBA, MantovaniG, MuscaritoliM, NewmanAB, Rossi-FanelliF, RosanoGM, RoubenoffR, SchambelanM, SokolGH, StorerTW, VellasB, von HaehlingS, YehSS, AnkerSD. Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc, 2011; 12:403–409.
30.
DeschenesMR. Effects of aging on muscle fibre type and size. Sports Med, 2004; 34:809–824.
31.
VerdijkLB, KoopmanR, SchaartG, MeijerK, SavelbergHH, van LoonLJ. Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. Am J Physiol Endocrinol Metab, 2007; 292:E151–E157.
32.
KumarV, SelbyA, RankinD, PatelR, AthertonP, HildebrandtW, WilliamsJ, SmithK, SeynnesO, HiscockN, RennieMJ. Age-related differences in the dose-response relationship of muscle protein synthesis to resistance exercise in young and old men. J Physiol, 2009; 587:211–217.
33.
VolpiE, NazemiR, FujitaS. Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care, 2004; 7:405–410.
KamelHK. Sarcopenia and aging. Nutr Rev, 2003; 61:157–167.
36.
HowardC, FerrucciL, SunK, FriedLP, WalstonJ, VaradhanR, GuralnikJM, SembaRD. Oxidative protein damage is associated with poor grip strength among older women living in the community. J Appl Physiol, 2007; 103:17–20.
37.
McKenzieD, BuaE, McKiernanS, CaoZ, AikenJM. Mitochondrial DNA deletion mutations: A causal role in sarcopenia. Eur J Biochem, 2002; 269:2010–2015.
38.
PakJW, HerbstA, BuaE, GokeyN, McKenzieD, AikenJM. Mitochondrial DNA mutations as a fundamental mechanism in physiological declines associated with aging. Aging Cell, 2003; 2:1–7.
39.
WanagatJ, CaoZ, PathareP, AikenJM. Mitochondrial DNA deletion mutations colocalize with segmental electron transport system abnormalities, muscle fiber atrophy, fiber splitting, and oxidative damage in sarcopenia. FASEB J, 2001; 15:322–332.
40.
AikenJ, BuaE, CaoZ, LopezM, WanagatJ, McKenzieD, McKiernanS. Mitochondrial DNA deletion mutations and sarcopenia. Ann NY Acad Sci, 2002; 959:412–423.
41.
CesariM, PahorM. Target population for clinical trials on sarcopenia. J Nutr Health Aging, 2008; 12:470–478.
42.
BaumgartnerRN, KoehlerKM, GallagherD, RomeroL, HeymsfieldSB, RossRR, GarryPJ, LindemanRD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol, 1998; 147:755–763.
43.
FrisoliAJr., ChavesPH, InghamSJ, FriedLP. Severe osteopenia and osteoporosis, sarcopenia, and frailty status in community-dwelling older women: Results from the Women's Health and Aging Study (WHAS) II. Bone, 2011; 48:952–957.
44.
JanssenI. Influence of sarcopenia on the development of physical disability: The Cardiovascular Health Study. J Am Geriatr Soc, 2006; 54:56–62.
45.
JanssenI, HeymsfieldSB, RossR. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc, 2002; 50:889–896.
46.
LauretaniF, RussoCR, BandinelliS, BartaliB, CavazziniC, Di IorioA, CorsiAM, RantanenT, GuralnikJM, FerrucciL. Age-associated changes in skeletal muscles and their effect on mobility: An operational diagnosis of sarcopenia. J Appl Physiol, 2003; 95:1851–1860.
47.
RollandY, Lauwers-CancesV, CournotM, NourhashemiF, ReynishW, RiviereD, VellasB, GrandjeanH. Sarcopenia, calf circumference, and physical function of elderly women: A cross-sectional study. J Am Geriatr Soc, 2003; 51:1120–1124.
48.
LandiF, LiperotiR, FuscoD, MastropaoloS, QuattrociocchiD, ProiaA, TosatoM, BernabeiR, OnderG. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc, 2012; 13:121–126.
49.
YehSS, LovittS, SchusterMW. Pharmacological treatment of geriatric cachexia: Evidence and safety in perspective. J Am Med Dir Assoc, 2007; 8:363–377.
ArgilesJM, AnkerSD, EvansWJ, MorleyJE, FearonKC, StrasserF, MuscaritoliM, BaracosVE. Consensus on cachexia definitions. J Am Med Dir Assoc, 2010; 11:229–230.
52.
RollandY, CzerwinskiS, Abellan Van KanG, MorleyJE, CesariM, OnderG, WooJ, BaumgartnerR, PillardF, BoirieY, ChumleaWM, VellasB. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging, 2008; 12:433–450.
53.
CesariM, VellasB. Sarcopenia: A novel clinical condition or still a matter for research?. J Am Med Dir Assoc, 2012; 13:766–767.
54.
von HaehlingS, MorleyJE, AnkerSD. An overview of sarcopenia: Facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle, 2010; 1:129–133.
55.
HeubergerRA. The frailty syndrome: A comprehensive review. J Nutr Gerontol Geriatr, 2011; 30:315–368.
56.
FriedLP, TangenCM, WalstonJ, NewmanAB, HirschC, GottdienerJ, SeemanT, TracyR, KopWJ, BurkeG, McBurnieMA. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci, 2001; 56:M146–M156.
57.
JonesDM, SongX, RockwoodK. Operationalizing a frailty index from a standardized comprehensive geriatric assessment. J Am Geriatr Soc, 2004; 52:1929–1933.
58.
SearleSD, MitnitskiA, GahbauerEA, GillTM, RockwoodK. A standard procedure for creating a frailty index. BMC Geriatr, 2008; 8:24.
MohlerMJ, FainMJ, WertheimerAM, NajafiB, Nikolich-ZugichJ. The Frailty syndrome: Clinical measurements and basic underpinnings in humans and animals. Exp Gerontol, 2014; 54:6–13.
61.
Garcia-GarciaFJ, Gutierrez AvilaG, Alfaro-AchaA, Amor AndresMS, De Los Angeles De La Torre LanzaM, Escribano AparicioMV, Humanes AparicioS, Larrion ZugastiJL, Gomez-Serranillo ReusM, Rodriguez-ArtalejoF, Rodriguez-ManasL. The prevalence of frailty syndrome in an older population from Spain. The Toledo Study for Healthy Aging. J Nutr Health Aging, 2011; 15:852–856.
62.
SternbergSA, Wershof SchwartzA, KarunananthanS, BergmanH, Mark ClarfieldA. The identification of frailty: A systematic literature review. J Am Geriatr Soc, 2011; 59:2129–2138.
63.
FriedLP, FerrucciL, DarerJ, WilliamsonJD, AndersonG. Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care. J Gerontol A Biol Sci Med Sci, 2004; 59:255–263.
64.
Chodzko-ZajkoWJ, ProctorDN, Fiatarone SinghMA, MinsonCT, NiggCR, SalemGJ, SkinnerJS. American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc, 2009; 41:1510–530.
65.
DeSouzaCA, ShapiroLF, ClevengerCM, DinennoFA, MonahanKD, TanakaH, SealsDR. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation, 2000; 102:1351–1357.
66.
GreenDJ, MaioranaA, O'DriscollG, TaylorR. Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol, 2004; 561:1–25.
67.
WalshJH, YongG, CheethamC, WattsGF, O'DriscollGJ, TaylorRR, GreenDJ. Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects. Eur Heart J, 2003; 24:1681–1689.
ButcherLR, ThomasA, BackxK, RobertsA, WebbR, MorrisK. Low-intensity exercise exerts beneficial effects on plasma lipids via PPARgamma. Med Sci Sports Exerc, 2008; 40:1263–1270.
70.
ThomasAW, DaviesNA, MoirH, WatkeysL, RuffinoJS, IsaSA, ButcherLR, HughesMG, MorrisK, WebbR. Exercise-associated generation of PPARgamma ligands activates PPARgamma signaling events and upregulates genes related to lipid metabolism. J Appl Physiol, 2012; 112:806–815.
71.
CharkoudianN, JoynerMJ, BarnesSA, JohnsonCP, EisenachJH, DietzNM, WallinBG. Relationship between muscle sympathetic nerve activity and systemic hemodynamics during nitric oxide synthase inhibition in humans. Am J Physiol Heart Circ Physiol, 2006; 291:H1378–H1383.
72.
BillmanGE. Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: Effect of endurance exercise training. Am J Physiol Heart Circ Physiol, 2009; 297:H1171–H1193.
73.
SealsDR, DinennoFA. Collateral damage: Cardiovascular consequences of chronic sympathetic activation with human aging. Am J Physiol Heart Circ Physiol, 2004; 287:H1895–H1905.
74.
BaronAD, LaaksoM, BrechtelG, HoitB, WattC, EdelmanSV. Reduced postprandial skeletal muscle blood flow contributes to glucose intolerance in human obesity. J Clin Endocrinol Metab, 1990; 70:1525–1533.
75.
LindL, LithellH. Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia. Am Heart J, 1993; 125:1494–1497.
NolanRP, JongP, Barry-BianchiSM, TanakaTH, FlorasJS. Effects of drug, biobehavioral and exercise therapies on heart rate variability in coronary artery disease: A systematic review. Eur J Cardiovasc Prev Rehabil, 2008; 15:386–396.
78.
RoutledgeFS, CampbellTS, McFetridge-DurdleJA, BaconSL. Improvements in heart rate variability with exercise therapy. Can J Cardiol, 2010; 26:303–312.
79.
LiuCJ, LathamNK. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev 2009CD002759.
80.
FiataroneMA, MarksEC, RyanND, MeredithCN, LipsitzLA, EvansWJ. High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA, 1990; 263:3029–3034.
81.
NelsonME, RejeskiWJ, BlairSN, DuncanPW, JudgeJO, KingAC, MaceraCA, Castaneda-SceppaC. Physical activity and public health in older adults: Recommendation from the American College of Sports Medicine and the American Heart Association. Circulation, 2007; 116:1094–1105.
82.
EarlesDR, JudgeJO, GunnarssonOT. Velocity training induces power-specific adaptations in highly functioning older adults. Arch Phys Med Rehabil, 2001; 82:872–878.
83.
EvansWJ. High-velocity resistance training for increasing peak muscle power in elderly women. Clin J Sport Med, 2003; 13:66.
84.
CaserottiP, AagaardP, LarsenJB, PuggaardL. Explosive heavy-resistance training in old and very old adults: Changes in rapid muscle force, strength and power. Scand J Med Sci Sports, 2008; 18:773–782.
85.
SayersSP, BeanJ, CuocoA, LeBrasseurNK, JetteA, FieldingRA. Changes in function and disability after resistance training: Does velocity matter?: A pilot study. Am J Phys Med Rehabil, 2003; 82:605–613.
86.
FieldingRA, LeBrasseurNK, CuocoA, BeanJ, MizerK, Fiatarone SinghMA. High-velocity resistance training increases skeletal muscle peak power in older women. J Am Geriatr Soc, 2002; 50:655–662.
87.
GreendaleGA, HirschSH, HahnTJ. The effect of a weighted vest on perceived health status and bone density in older persons. Qual Life Res, 1993; 2:141–152.
88.
ShawJM, SnowCM. Weighted vest exercise improves indices of fall risk in older women. J Gerontol A Biol Sci Med Sci, 1998; 53:M53–M58.
89.
BeanJ, HermanS, KielyDK, CallahanD, MizerK, FronteraWR, FieldingRA. Weighted stair climbing in mobility-limited older people: A pilot study. J Am Geriatr Soc, 2002; 50:663–670.
90.
GreendaleGA, SalemGJ, YoungJT, DamesynM, MarionM, WangMY, ReubenDB. A randomized trial of weighted vest use in ambulatory older adults: Strength, performance, and quality of life outcomes. J Am Geriatr Soc, 2000; 48:305–311.
91.
FaberMJ, BosscherRJ, ChinAPMJ, van WieringenPC. Effects of exercise programs on falls and mobility in frail and pre-frail older adults: A multicenter randomized controlled trial. Arch Phys Med Rehabil, 2006; 87:885–896.
92.
Serra-RexachJA, Bustamante-AraN, Hierro VillaranM, Gonzalez GilP, Sanz IbanezMJ, Blanco SanzN, Ortega SantamariaV, Gutierrez SanzN, Marin PradaAB, GallardoC, Rodriguez RomoG, RuizJR, LuciaA. Short-term, light- to moderate-intensity exercise training improves leg muscle strength in the oldest old: A randomized controlled trial. J Am Geriatr Soc, 2011; 59:594–602.
93.
LustosaLP, SilvaJP, CoelhoFM, PereiraDS, ParentoniAN, PereiraLS. Impact of resistance exercise program on functional capacity and muscular strength of knee extensor in pre-frail community-dwelling older women: A randomized crossover trial. Rev Bras Fisioter, 2011; 15:318–324.
94.
SullivanDH, RobersonPK, SmithES, PriceJA, BoppMM. Effects of muscle strength training and megestrol acetate on strength, muscle mass, and function in frail older people. J Am Geriatr Soc, 2007; 55:20–28.
95.
HaskellWL, LeeIM, PateRR, PowellKE, BlairSN, FranklinBA, MaceraCA, HeathGW, ThompsonPD, BaumanA. Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation, 2007; 116:1081–1093.
96.
VillarealDT, SmithGI, SinacoreDR, ShahK, MittendorferB. Regular multicomponent exercise increases physical fitness and muscle protein anabolism in frail, obese, older adults. Obesity (Silver Spring), 2011; 19:312–318.
97.
LordSR, CastellS, CorcoranJ, DayhewJ, MattersB, ShanA, WilliamsP. The effect of group exercise on physical functioning and falls in frail older people living in retirement villages: A randomized, controlled trial. J Am Geriatr Soc, 2003; 51:1685–1692.
98.
EhsaniAA, SpinaRJ, PetersonLR, RinderMR, GloverKL, VillarealDT, BinderEF, HolloszyJO. Attenuation of cardiovascular adaptations to exercise in frail octogenarians. J Appl Physiol, 2003; 95:1781–1788.
99.
de VriesNM, van RavensbergCD, HobbelenJS, Olde RikkertMG, StaalJB, Nijhuis-van der SandenMW. Effects of physical exercise therapy on mobility, physical functioning, physical activity and quality of life in community-dwelling older adults with impaired mobility, physical disability and/or multi-morbidity: A meta-analysis. Ageing Res Rev, 2012; 11:136–149.
JiLL, Gomez-CabreraMC, SteinhafelN, VinaJ. Acute exercise activates nuclear factor (NF)-kappaB signaling pathway in rat skeletal muscle. FASEB J, 2004; 18:1499–1506.
102.
VinaJ, Sanchis-GomarF, Martinez-BelloV, Gomez-CabreraMC. Exercise acts as a drug; the pharmacological benefits of exercise. Br J Pharmacol, 2012; 167:1–12.
103.
EganB, ZierathJR. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab, 2013; 17:162–184.
104.
PilegaardH, SaltinB, NeuferPD. Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol, 2003; 546:851–858.
105.
MahoneyDJ, PariseG, MelovS, SafdarA, TarnopolskyMA. Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J, 2005; 19:1498–1500.
106.
CoffeyVG, ShieldA, CannyBJ, CareyKA, Cameron-SmithD, HawleyJA. Interaction of contractile activity and training history on mRNA abundance in skeletal muscle from trained athletes. Am J Physiol Endocrinol Metab, 2006; 290:E849–E855.
107.
LouisE, RaueU, YangY, JemioloB, TrappeS. Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle. J Appl Physiol, 2007; 103:1744–1751.
108.
McGeeSL, FairlieE, GarnhamAP, HargreavesM. Exercise-induced histone modifications in human skeletal muscle. J Physiol, 2009; 587:5951–5958.
109.
BaarK, WendeAR, JonesTE, MarisonM, NolteLA, ChenM, KellyDP, HolloszyJO. Adaptations of skeletal muscle to exercise: Rapid increase in the transcriptional coactivator PGC-1. FASEB J, 2002; 16:1879–1886.
110.
WrightDC, HanDH, Garcia-RovesPM, GeigerPC, JonesTE, HolloszyJO. Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1alpha expression. J Biol Chem, 2007; 282:194–199.
111.
Fiuza-LucesC, GaratacheaN, BergerNA, LuciaA. Exercise is the real polypill. Physiology (Bethesda), 2013; 28:330–358.
112.
BerchtoldMW, BrinkmeierH, MuntenerM. Calcium ion in skeletal muscle: Its crucial role for muscle function, plasticity, and disease. Physiol Rev, 2000; 80:1215–1265.
113.
WrightDC, HuckerKA, HolloszyJO, HanDH. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes, 2004; 53:330–335.
114.
RaneyMA, TurcotteLP. Evidence for the involvement of CaMKII and AMPK in Ca2+-dependent signaling pathways regulating FA uptake and oxidation in contracting rodent muscle. J Appl Physiol, 2008; 104:1366–1373.
115.
WuH, KanatousSB, ThurmondFA, GallardoT, IsotaniE, Bassel-DubyR, WilliamsRS. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science, 2002; 296:349–352.
116.
GoodyearLJ, ChangPY, SherwoodDJ, DufresneSD, MollerDE. Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Am J Physiol, 1996; 271:E403–E408.
AkimotoT, PohnertSC, LiP, ZhangM, GumbsC, RosenbergPB, WilliamsRS, YanZ. Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem, 2005; 280:19587–19593.
119.
LongYC, WidegrenU, ZierathJR. Exercise-induced mitogen-activated protein kinase signalling in skeletal muscle. Proc Nutr Soc, 2004; 63:227–232.
120.
SalminenA, VihkoV. Endurance training reduces the susceptibility of mouse skeletal muscle to lipid peroxidation in vitro. Acta Physiol Scand, 1983; 117:109–113.
121.
Gomez-CabreraMC, DomenechE, VinaJ. Moderate exercise is an antioxidant: Upregulation of antioxidant genes by training. Free Radic Biol Med, 2008; 44:126–131.
122.
PowersSK, DuarteJ, KavazisAN, TalbertEE. Reactive oxygen species are signalling molecules for skeletal muscle adaptation. Exp Physiol, 2010; 95:1–9.
123.
PetersenAC, McKennaMJ, MedvedI, MurphyKT, BrownMJ, Della GattaP, Cameron-SmithD. Infusion with the antioxidant N-acetylcysteine attenuates early adaptive responses to exercise in human skeletal muscle. Acta Physiol (Oxf), 2012; 204:382–392.
124.
PedersenBK, FebbraioMA. Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat Rev Endocrinol, 2012; 8:457–465.
CarlingD, HardieDG. The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. Biochim Biophys Acta, 1989; 1012:81–86.
127.
BergeronR, RenJM, CadmanKS, MooreIK, PerretP, PypaertM, YoungLH, SemenkovichCF, ShulmanGI. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab, 2001; 281:E1340–E1346.
128.
JagerS, HandschinC, St-PierreJ, SpiegelmanBM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA, 2007; 104:12017–12022.
129.
KahnBB, AlquierT, CarlingD, HardieDG. AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab, 2005; 1:15–25.
130.
McGeeSL, van DenderenBJ, HowlettKF, MollicaJ, SchertzerJD, KempBE, HargreavesM. AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes, 2008; 57:860–867.
LagougeM, ArgmannC, Gerhart-HinesZ, MezianeH, LerinC, DaussinF, MessadeqN, MilneJ, LambertP, ElliottP, GenyB, LaaksoM, PuigserverP, AuwerxJ. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 2006; 127:1109–1122.
135.
Gerhart-HinesZ, RodgersJT, BareO, LerinC, KimSH, MostoslavskyR, AltFW, WuZ, PuigserverP. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J, 2007; 26:1913–1923.
136.
BodineSC, StittTN, GonzalezM, KlineWO, StoverGL, BauerleinR, ZlotchenkoE, ScrimgeourA, LawrenceJC, GlassDJ, YancopoulosGD. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol, 2001; 3:1014–1019.
137.
SandriM. Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda)., 2008; 23:160–170.
138.
KlossnerS, DurieuxAC, FreyssenetD, FlueckM. Mechano-transduction to muscle protein synthesis is modulated by FAK. Eur J Appl Physiol, 2009; 106:389–398.
139.
DurieuxAC, D'AntonaG, DesplanchesD, FreyssenetD, KlossnerS, BottinelliR, FluckM. Focal adhesion kinase is a load-dependent governor of the slow contractile and oxidative muscle phenotype. J Physiol, 2009; 587:3703–3717.
140.
WilkinsonSB, PhillipsSM, AthertonPJ, PatelR, YarasheskiKE, TarnopolskyMA, RennieMJ. Differential effects of resistance and endurance exercise in the fed state on signalling molecule phosphorylation and protein synthesis in human muscle. J Physiol, 2008; 586:3701–3717.
SchmutzS, DappC, WittwerM, VogtM, HoppelerH, FluckM. Endurance training modulates the muscular transcriptome response to acute exercise. Pflugers Arch, 2006; 451:678–687.
143.
TaylorCT. Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem J, 2008; 409:19–26.
144.
MeeusenR. Exercise, nutrition and the brain. Sports Med, 2014; 44(Suppl 1):S47–S56.
145.
EllisT, MotlRW. Physical activity behavior change in persons with neurologic disorders: Overview and examples from Parkinson disease and multiple sclerosis. J Neurol Phys Ther, 2013; 37:85–90.
146.
QuerfurthHW, LaFerlaFM. Alzheimer's disease. N Engl J Med, 2010; 362:329–344.
147.
LuciaA, RuizJR. Exercise is beneficial for patients with Alzheimer's disease: A call for action. Br J Sports Med, 2011; 45:468–469.
148.
Santana-SosaE, BarriopedroMI, Lopez-MojaresLM, PerezM, LuciaA. Exercise training is beneficial for Alzheimer's patients. Int J Sports Med, 2008; 29:845–850.
149.
RadakZ, HartN, SargaL, KoltaiE, AtalayM, OhnoH, BoldoghI. Exercise plays a preventive role against Alzheimer's disease. J Alzheimers Dis., 2010; 20:777–783.
150.
RadakZ, IhaszF, KoltaiE, GotoS, TaylorAW, BoldoghI. The redox-associated adaptive response of brain to physical exercise. Free Radic Res, 2014; 48:84–92.
BondySC. Reactive oxygen species: Relation to aging and neurotoxic damage. Neurotoxicology, 1992; 13:87–100.
157.
PacificiRE, DaviesKJ. Protein, lipid and DNA repair systems in oxidative stress: The free-radical theory of aging revisited. Gerontology, 1991; 37:166–180.
KnaepenK, GoekintM, HeymanEM, MeeusenR. Neuroplasticity - exercise-induced response of peripheral brain-derived neurotrophic factor: A systematic review of experimental studies in human subjects. Sports Med, 2010; 40:765–801.
163.
NagaharaAH, MerrillDA, CoppolaG, TsukadaS, SchroederBE, ShakedGM, WangL, BleschA, KimA, ConnerJM, RockensteinE, ChaoMV, KooEH, GeschwindD, MasliahE, ChibaAA, TuszynskiMH. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med, 2009; 15:331–337.
164.
FerrisLT, WilliamsJS, ShenCL. The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function. Med Sci Sports Exerc, 2007; 39:728–734.
165.
Schmidt-KassowM, SchadleS, OtterbeinS, ThielC, DoehringA, LotschJ, KaiserJ. Kinetics of serum brain-derived neurotrophic factor following low-intensity versus high-intensity exercise in men and women. Neuroreport, 2012; 23:889–893.
CotmanCW, BerchtoldNC. Exercise: A behavioral intervention to enhance brain health and plasticity. Trends Neurosci, 2002; 25:295–301.
168.
Gomez-PinillaF, YingZ, RoyRR, MolteniR, EdgertonVR. Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity. J Neurophysiol, 2002; 88:2187–2195.
169.
MousaviK, ParryDJ, JasminBJ. BDNF rescues myosin heavy chain IIB muscle fibers after neonatal nerve injury. Am J Physiol Cell Physiol, 2004; 287:C22–C29.
170.
VaynmanS, YingZ, Gomez-PinillaF. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci, 2004; 20:2580–2590.
171.
MurphyDD, SegalM. Morphological plasticity of dendritic spines in central neurons is mediated by activation of cAMP response element binding protein. Proc Natl Acad Sci USA, 1997; 94:1482–1487.
172.
MiyamotoE. Molecular mechanism of neuronal plasticity: Induction and maintenance of long-term potentiation in the hippocampus. J Pharmacol Sci., 2006; 100:433–442.
173.
ChengA, WanR, YangJL, KamimuraN, SonTG, OuyangX, LuoY, OkunE, MattsonMP. Involvement of PGC-1alpha in the formation and maintenance of neuronal dendritic spines. Nat Commun, 2012; 3:1250.
174.
CarlezonWAJr., DumanRS, NestlerEJ. The many faces of CREB. Trends Neurosci, 2005; 28:436–445.
175.
VaynmanS, YingZ, Gomez-PinillaF. Interplay between brain-derived neurotrophic factor and signal transduction modulators in the regulation of the effects of exercise on synaptic-plasticity. Neuroscience, 2003; 122:647–657.
NeeperSA, Gomez-PinillaF, ChoiJ, CotmanCW. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res, 1996; 726:49–56.
182.
RevillaS, SunolC, Garcia-MesaY, Gimenez-LlortL, SanfeliuC, CristofolR. Physical exercise improves synaptic dysfunction and recovers the loss of survival factors in 3xTg-AD mouse brain. Neuropharmacology, 2014; 81:55–63.
183.
KooHM, LeeSM, KimMH. Spontaneous Wheel running exercise induces brain recovery via neurotrophin-3 expression following experimental traumatic brain injury in rats. J Phys Ther Sci, 2013; 25:1103–1107.
184.
ChungJY, KimMW, BangMS, KimM. Increased expression of neurotrophin 4 following focal cerebral ischemia in adult rat brain with treadmill exercise. PLoS One, 2013; 8:e52461.
185.
ErikssonPS, PerfilievaE, Bjork-ErikssonT, AlbornAM, NordborgC, PetersonDA, GageFH. Neurogenesis in the adult human hippocampus. Nat Med, 1998; 4:1313–1317.
186.
VivarC, PotterMC, van PraagH. All about running: Synaptic plasticity, growth factors and adult hippocampal neurogenesis. Curr Top Behav Neurosci, 2013; 15:189–210.
187.
van PraagH, ChristieBR, SejnowskiTJ, GageFH. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad Sci USA, 1999; 96:13427–13431.
188.
RossiC, AngelucciA, CostantinL, BraschiC, MazzantiniM, BabbiniF, FabbriME, TessarolloL, MaffeiL, BerardiN, CaleoM. Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. Eur J Neurosci Oct, 2006; 24:1850–1856.
189.
BathKG, AkinsMR, LeeFS. BDNF control of adult SVZ neurogenesis. Dev Psychobiol, 2012; 54:578–589.
DehvariN, MahmudT, PerssonJ, BengtssonT, GraffC, WinbladB, RonnbackA, BehbahaniH. Amyloid precursor protein accumulates in aggresomes in response to proteasome inhibitor. Neurochem Int, 2012; 60:533–542.
193.
LeeMJ, LeeJH, RubinszteinDC. Tau degradation: The ubiquitin-proteasome system versus the autophagy-lysosome system. Prog Neurobiol, 2013; 105:49–59.
194.
Lopez-SalonM, AlonsoM, ViannaMR, ViolaH, Mello e SouzaT, IzquierdoI, PasquiniJM, MedinaJH. The ubiquitin-proteasome cascade is required for mammalian long-term memory formation. Eur J Neurosci, 2001; 14:1820–1826.
195.
KarpovaA, MikhaylovaM, ThomasU, KnopfelT, BehnischT. Involvement of protein synthesis and degradation in long-term potentiation of Schaffer collateral CA1 synapses. J Neurosci, 2006; 26:4949–4955.
196.
López-OtínC, BlascoMA, PartridgeL, SerranoM, KroemerG. The hallmarks of aging. Cell, 2013; 153:1194–1217.
Gomez-CabreraMC, Sanchis-GomarF, Garcia-VallesR, Pareja-GaleanoH, GambiniJ, BorrasC, VinaJ. Mitochondria as sources and targets of damage in cellular aging. Clin Chem Lab Med, 2012; 50:1287–1295.
199.
PariseG, BroseAN, TarnopolskyMA. Resistance exercise training decreases oxidative damage to DNA and increases cytochrome oxidase activity in older adults. Exp Gerontol, 2005; 40:173–180.
200.
RadakZ, NaitoH, KanekoT, TaharaS, NakamotoH, TakahashiR, Cardozo-PelaezF, GotoS. Exercise training decreases DNA damage and increases DNA repair and resistance against oxidative stress of proteins in aged rat skeletal muscle. Pflugers Archiv, 2002; 445:273–278.
201.
LeickL, LyngbySS, WojtaszewskiJF, PilegaardH. PGC-1alpha is required for training-induced prevention of age-associated decline in mitochondrial enzymes in mouse skeletal muscle. Exp Gerontol, 2010; 45:336–342.
202.
AvivA, ValdesA, GardnerJP, SwaminathanR, KimuraM, SpectorTD. Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. J Clin Endocrinol Metab, 2006; 91:635–640.
203.
BenetosA, OkudaK, LajemiM, KimuraM, ThomasF, SkurnickJ, LabatC, BeanK, AvivA. Telomere length as an indicator of biological aging: The gender effect and relation with pulse pressure and pulse wave velocity. Hypertension, 2001; 37:381–385.
204.
BrouiletteS, SinghRK, ThompsonJR, GoodallAH, SamaniNJ. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol, 2003; 23:842–846.
205.
GardnerJP, LiS, SrinivasanSR, ChenW, KimuraM, LuX, BerensonGS, AvivA. Rise in insulin resistance is associated with escalated telomere attrition. Circulation, 2005; 111:2171–2177.
206.
JeanclosE, SchorkNJ, KyvikKO, KimuraM, SkurnickJH, AvivA. Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension, 2000; 36:195–200.
207.
NawrotTS, StaessenJA, GardnerJP, AvivA. Telomere length and possible link to X chromosome. Lancet, 2004; 363:507–510.
SampsonMJ, WinterboneMS, HughesJC, DozioN, HughesDA. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care, 2006; 29:283–289.
210.
ValdesAM, AndrewT, GardnerJP, KimuraM, OelsnerE, CherkasLF, AvivA, SpectorTD. Obesity, cigarette smoking, and telomere length in women. Lancet, 2005; 366:662–664.
211.
CherkasLF, HunkinJL, KatoBS, RichardsJB, GardnerJP, SurdulescuGL, KimuraM, LuX, SpectorTD, AvivA. The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med, 2008; 168:154–158.
212.
DenhamJ, NelsonCP, O'BrienBJ, NankervisSA, DenniffM, HarveyJT, MarquesFZ, CoddV, Zukowska-SzczechowskaE, SamaniNJ, TomaszewskiM, CharcharFJ. Longer leukocyte telomeres are associated with ultra-endurance exercise independent of cardiovascular risk factors. PLoS One, 2013; 8:e69377.
213.
LaRoccaTJ, SealsDR, PierceGL. Leukocyte telomere length is preserved with aging in endurance exercise-trained adults and related to maximal aerobic capacity. Mech Ageing Dev, 2010; 131:165–167.
214.
LudlowAT, ZimmermanJB, WitkowskiS, HearnJW, HatfieldBD, RothSM. Relationship between physical activity level, telomere length, and telomerase activity. Med Sci Sports Exerc, 2008; 40:1764–1771.
215.
PutermanE, LinJ, BlackburnE, O'DonovanA, AdlerN, EpelE. The power of exercise: Buffering the effect of chronic stress on telomere length. PLoS One, 2010; 5:e10837.
216.
WernerC, FursterT, WidmannT, PossJ, RoggiaC, HanhounM, ScharhagJ, BuchnerN, MeyerT, KindermannW, HaendelerJ, BohmM, LaufsU. Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall. Circulation, 2009; 120:2438–2447.
217.
LayeMJ, SolomonTP, KarstoftK, PedersenKK, NielsenSD, PedersenBK. Increased shelterin mRNA expression in peripheral blood mononuclear cells and skeletal muscle following an ultra-long-distance running event. J Appl Physiol, 2012; 112:773–781.
218.
OsthusIB, SguraA, BerardinelliF, AlsnesIV, BronstadE, RehnT, StobakkPK, HatleH, WisloffU, NaumanJ. Telomere length and long-term endurance exercise: Does exercise training affect biological age? A pilot study. PLoS One, 2012; 7:e52769.
219.
SavelaS, SaijonmaaO, StrandbergTE, KoistinenP, StrandbergAY, TilvisRS, PitkalaKH, MiettinenTA, FyhrquistF. Physical activity in midlife and telomere length measured in old age. Exp Gerontol, 2013; 48:81–84.
220.
KodamaS, SaitoK, TanakaS, MakiM, YachiY, AsumiM, SugawaraA, TotsukaK, ShimanoH, OhashiY, YamadaN, SoneH. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: A meta-analysis. JAMA, 2009; 301:2024–2035.
221.
ChiltonWL, MarquesFZ, WestJ, KannourakisG, BerzinsSP, O'BrienBJ, CharcharFJ. Acute exercise leads to regulation of telomere-associated genes and microRNA expression in immune cells. PLoS One, 2014; 9:e92088.
222.
TosatoM, ZamboniV, FerriniA, CesariM. The aging process and potential interventions to extend life expectancy. Clin Interv Aging, 2007; 2:401–412.
223.
LudlowAT, RothSM. Physical activity and telomere biology: Exploring the link with aging-related disease prevention. J Aging Res, 2011; 2011:790378.
LingC, RonnT. Epigenetic adaptation to regular exercise in humans. Drug Discov Today, 2014; doi:10.1016/j.drudis.2014.03.006.
228.
WernerC, HanhounM, WidmannT, KazakovA, SemenovA, PossJ, BauersachsJ, ThumT, PfreundschuhM, MullerP, HaendelerJ, BohmM, LaufsU. Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis. J Am Coll Cardiol, 2008; 52:470–482.
229.
WolfSA, MelnikA, KempermannG. Physical exercise increases adult neurogenesis and telomerase activity, and improves behavioral deficits in a mouse model of schizophrenia. Brain Behav Immun, 2011; 25:971–980.
PerryCG, LallyJ, HollowayGP, HeigenhauserGJ, BonenA, SprietLL. Repeated transient mRNA bursts precede increases in transcriptional and mitochondrial proteins during training in human skeletal muscle. J Physiol, 2010; 588:4795–4810.
232.
HolloszyJO, CoyleEF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol, 1984; 56:831–838.
233.
BoothFW, ThomasonDB. Molecular and cellular adaptation of muscle in response to exercise: Perspectives of various models. Physiol Rev, 1991; 71:541–585.
234.
RasmussenM, ZierathJR, BarresR. Dynamic epigenetic responses to muscle contraction. Drug Discov Today, 2014; 19:1010–1014.
235.
RasmussenM, ZierathJR, BarresR. Dynamic epigenetic responses to muscle contraction. Drug Discov Today, 2014.
236.
PotthoffMJ, WuH, ArnoldMA, SheltonJM, BacksJ, McAnallyJ, RichardsonJA, Bassel-DubyR, OlsonEN. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest, 2007; 117:2459–2467.
237.
DayehTA, OlssonAH, VolkovP, AlmgrenP, RonnT, LingC. Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets. Diabetologia, 2013; 56:1036–1046.
238.
NitertMD, DayehT, VolkovP, ElgzyriT, HallE, NilssonE, YangBT, LangS, ParikhH, WessmanY, WeishauptH, AttemaJ, AbelsM, WierupN, AlmgrenP, JanssonPA, RonnT, HanssonO, ErikssonKF, GroopL, LingC. Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes. Diabetes, 2012; 61:3322–3332.
239.
KalimanP, ParrizasM, LalanzaJF, CaminsA, EscorihuelaRM, PallasM. Neurophysiological and epigenetic effects of physical exercise on the aging process. Ageing Res Rev, 2011; 10:475–486.
240.
NakajimaK, TakeokaM, MoriM, HashimotoS, SakuraiA, NoseH, HiguchiK, ItanoN, ShioharaM, OhT, TaniguchiS. Exercise effects on methylation of ASC gene. Int J Sports Med, 2010; 31:671–675.
241.
RonnT, VolkovP, DavegardhC, DayehT, HallE, OlssonAH, NilssonE, TornbergA, Dekker NitertM, ErikssonKF, JonesHA, GroopL, LingC. A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet, 2013; 9:e1003572.
242.
Sanchis-GomarF, Garcia-GimenezJL, Perez-QuilisC, Gomez-CabreraMC, PallardoFV, LippiG. Physical exercise as an epigenetic modulator: Eustress, the “positive stress” as an effector of gene expression. J Strength Cond Res, 2012; 26:3469–3472.
RaueU, SlivkaD, JemioloB, HollonC, TrappeS. Myogenic gene expression at rest and after a bout of resistance exercise in young (18–30 yr) and old (80–89 yr) women. J Appl Physiol, 2006; 101:53–59.
KogaH, KaushikS, CuervoAM. Protein homeostasis and aging: The importance of exquisite quality control. Ageing Res Rev, 2010; 10:205–215.
247.
PowersET, MorimotoRI, DillinA, KellyJW, BalchWE. Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem, 2009; 78:959–991.
248.
RubinszteinDC, MarinoG, KroemerG. Autophagy and aging. Cell, 2011; 146:682–695.
249.
TomaruU, TakahashiS, IshizuA, MiyatakeY, GohdaA, SuzukiS, OnoA, OharaJ, BabaT, MurataS, TanakaK, KasaharaM. Decreased proteasomal activity causes age-related phenotypes and promotes the development of metabolic abnormalities. Am J Pathol, 2012; 180:963–972.
250.
TanidaI. Autophagosome formation and molecular mechanism of autophagy. Antioxid Redox Signal, 2010; 14:2201–2214.
251.
HeC, SumpterRJr., LevineB. Exercise induces autophagy in peripheral tissues and in the brain. Autophagy, 2012; 8:1548–1551.
252.
Fiuza-LucesC, DelmiroA, Soares-MirandaL, Gonzalez-MurilloA, Martinez-PalaciosJ, RamirezM, LuciaA, MoranM. Exercise training can induce cardiac autophagy at end-stage chronic conditions: Insights from a graft-versus-host-disease mouse model. Brain Behav Immun., 2014; 39:56–60.
253.
KimYA, KimYS, OhSL, KimHJ, SongW. Autophagic response to exercise training in skeletal muscle with age. J Physiol Biochem, 2013; 69:697–705.
254.
LuoL, LuAM, WangY, HongA, ChenY, HuJ, LiX, QinZH. Chronic resistance training activates autophagy and reduces apoptosis of muscle cells by modulating IGF-1 and its receptors, Akt/mTOR and Akt/FOXO3a signaling in aged rats. Exp Gerontol, 2013; 48:427–436.
255.
WohlgemuthSE, LeesHA, MarzettiE, ManiniTM, ArandaJM, DanielsMJ, PahorM, PerriMG, LeeuwenburghC, AntonSD. An exploratory analysis of the effects of a weight loss plus exercise program on cellular quality control mechanisms in older overweight women. Rejuvenation Res, 2011; 14:315–324.
PickfordF, MasliahE, BritschgiM, LucinK, NarasimhanR, JaegerPA, SmallS, SpencerB, RockensteinE, LevineB, Wyss-CorayT. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest, 2008; 118:2190–2199.
258.
LipinskiMM, ZhengB, LuT, YanZ, PyBF, NgA, XavierRJ, LiC, YanknerBA, ScherzerCR, YuanJ. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci USA, 2010; 107:14164–14169.
259.
EmanueleE, MinorettiP, Sanchis-GomarF, Pareja-GaleanoH, YilmazY, GaratacheaN, LuciaA. Can enhanced autophagy be associated with human longevity? Serum levels of the autophagy biomarker beclin-1 are increased in healthy centenarians. Rejuvenation Res, 2014; 17:518–524.
260.
MacKenzieMG, HamiltonDL, MurrayJT, TaylorPM, BaarK. mVps34 is activated following high-resistance contractions. J Physiol, 2009; 587:253–260.
261.
WohlgemuthSE, SeoAY, MarzettiE, LeesHA, LeeuwenburghC. Skeletal muscle autophagy and apoptosis during aging: Effects of calorie restriction and life-long exercise. Exp Gerontol, 2010; 45:138–148.
262.
ZagliaT, MilanG, RuhsA, FranzosoM, BertaggiaE, PiancaN, CarpiA, CarulloP, PesceP, SacerdotiD, SaraisC, CatalucciD, KrugerM, MongilloM, SandriM. Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy. J Clin Invest, 2014; 124:2410–2424.
263.
SandriM, SandriC, GilbertA, SkurkC, CalabriaE, PicardA, WalshK, SchiaffinoS, LeckerSH, GoldbergAL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell, 2004; 117:399–412.
264.
ZagliaT, MilanG, FranzosoM, BertaggiaE, PiancaN, PiasentiniE, VoltarelliVA, ChiavegatoD, BrumPC, GlassDJ, SchiaffinoS, SandriM, MongilloM. Cardiac sympathetic neurons provide trophic signal to the heart via beta2-adrenoceptor-dependent regulation of proteolysis. Cardiovasc Res, 2013; 97:240–250.
265.
CoiroV, VolpiR, GramelliniD, MaffeiML, VoltaE, MelaniA, ChioderaP. Effect of physical training on age-related reduction of GH secretion during exercise in normally cycling women. Maturitas, 2010; 65:392–395.
266.
FujitaS, RasmussenBB, CadenasJG, DrummondMJ, GlynnEL, SattlerFR, VolpiE. Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling. Diabetes, 2007; 56:1615–1622.
267.
MayhewDL, KimJS, CrossJM, FerrandoAA, BammanMM. Translational signaling responses preceding resistance training-mediated myofiber hypertrophy in young and old humans. J Appl Physiol, 2009; 107:1655–1662.
268.
PasiakosSM. Exercise and amino acid anabolic cell signaling and the regulation of skeletal muscle mass. Nutrients, 2012; 4:740–758.
269.
MannS, BeedieC, BalducciS, ZanusoS, AllgroveJ, BertiatoF, JimenezA. Changes in insulin sensitivity in response to different modalities of exercise: A review of the evidence. Diabetes Metab Res Rev, 2014; 30:237–268.
270.
KraemerWJ, MarchitelliL, GordonSE, HarmanE, DziadosJE, MelloR, FrykmanP, McCurryD, FleckSJ. Hormonal and growth factor responses to heavy resistance exercise protocols. J Appl Physiol, 1990; 69:1442–1450.
271.
GotshalkLA, LoebelCC, NindlBC, PutukianM, SebastianelliWJ, NewtonRU, HakkinenK, KraemerWJ. Hormonal responses of multiset versus single-set heavy-resistance exercise protocols. Can J Appl Physiol, 1997; 22:244–255.
272.
KraemerWJ, NobleBJ, ClarkMJ, CulverBW. Physiologic responses to heavy-resistance exercise with very short rest periods. Int J Sports Med, 1987; 8:247–252.
273.
KraemerWJ, RatamessNA. Hormonal responses and adaptations to resistance exercise and training. Sports Med, 2005; 35:339–361.
274.
WestDW, KujbidaGW, MooreDR, AthertonP, BurdNA, PadzikJP, De LisioM, TangJE, PariseG, RennieMJ, BakerSK, PhillipsSM. Resistance exercise-induced increases in putative anabolic hormones do not enhance muscle protein synthesis or intracellular signalling in young men. J Physiol, 2009; 587:5239–5247.
275.
HartmanJW, MooreDR, PhillipsSM. Resistance training reduces whole-body protein turnover and improves net protein retention in untrained young males. Appl Physiol Nutr Metab, 2006; 31:557–564.
276.
YarasheskiKE, ZachwiejaJJ, BierDM. Acute effects of resistance exercise on muscle protein synthesis rate in young and elderly men and women. Am J Physiol, 1993; 265:E210–E214.
277.
YarasheskiKE, Pak-LoducaJ, HastenDL, ObertKA, BrownMB, SinacoreDR. Resistance exercise training increases mixed muscle protein synthesis rate in frail women and men >/=76 yr old. Am J Physiol, 1999; 277:E118–E125.
278.
EsmarckB, AndersenJL, OlsenS, RichterEA, MizunoM, KjaerM. Timing of postexercise protein intake is important for muscle hypertrophy with resistance training in elderly humans. J Physiol, 2001; 535:301–311.
279.
KosekDJ, KimJS, PetrellaJK, CrossJM, BammanMM. Efficacy of 3 days/wk resistance training on myofiber hypertrophy and myogenic mechanisms in young vs. older adults. J Appl Physiol, 2006; 101:531–544.
280.
DrummondMJ, DreyerHC, PenningsB, FryCS, DhananiS, DillonEL, Sheffield-MooreM, VolpiE, RasmussenBB. Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J Appl Physiol, 2008; 104:1452–1461.
281.
WelleS, ThorntonC, StattM. Myofibrillar protein synthesis in young and old human subjects after three months of resistance training. Am J Physiol, 1995; 268:E422–E427.
282.
AnianssonA, GrimbyG, RundgrenA. Isometric and isokinetic quadriceps muscle strength in 70-year-old men and women. Scand J Rehabil Med, 1980; 12:161–168.
283.
LinnaneAW, BaumerA, MaxwellRJ, PrestonH, ZhangCF, MarzukiS. Mitochondrial gene mutation: The ageing process and degenerative diseases. Biochem Int, 1990; 22:1067–1076.
284.
CortopassiGA, ArnheimN. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res, 1990; 18:6927–6933.
285.
CortopassiGA, ShibataD, SoongNW, ArnheimN. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci USA, 1992; 89:7370–7374.
286.
DerbreF, Gomez-CabreraMC, NascimentoAL, Sanchis-GomarF, Martinez-BelloVE, TresguerresJA, FuentesT, Gratas-DelamarcheA, MonsalveM, VinaJ. Age associated low mitochondrial biogenesis may be explained by lack of response of PGC-1alpha to exercise training. Age (Dordr), 2012; 34:669–679.
287.
BroskeyNT, GreggioC, BossA, BoutantM, DwyerA, SchlueterL, HansD, GremionG, KreisR, BoeschC, CantoC, AmatiF. Skeletal muscle mitochondria in the elderly: Effects of physical fitness and exercise training. J Clin Endocrinol Metab, 2014; 99:1852–1861.
288.
HarmanD. Aging: A theory based on free radical and radiation chemistry. J Gerontol, 1956; 11:298–300.
289.
HebertSL, LanzaIR, NairKS. Mitochondrial DNA alterations and reduced mitochondrial function in aging. Mech Ageing Dev, 2010; 131:451–462.
290.
ShortKR, BigelowML, KahlJ, SinghR, Coenen-SchimkeJ, RaghavakaimalS, NairKS. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci USA, 2005; 102:5618–5623.
291.
LanzaIR, ShortDK, ShortKR, RaghavakaimalS, BasuR, JoynerMJ, McConnellJP, NairKS. Endurance exercise as a countermeasure for aging. Diabetes, 2008; 57:2933–2942.
292.
RooyackersOE, AdeyDB, AdesPA, NairKS. Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc Natl Acad Sci USA, 1996; 93:15364–15369.
293.
WelleS, BhattK, ThorntonCA. High-abundance mRNAs in human muscle: Comparison between young and old. J Appl Physiol, 2000; 89:297–304.
294.
ZahnJM, SonuR, VogelH, CraneE, Mazan-MamczarzK, RabkinR, DavisRW, BeckerKG, OwenAB, KimSK. Transcriptional profiling of aging in human muscle reveals a common aging signature. PLoS Genet Jul, 2006; 2:e115.
295.
MelovS, TarnopolskyMA, BeckmanK, FelkeyK, HubbardA. Resistance exercise reverses aging in human skeletal muscle. PLoS One, 2007; 2:e465.
296.
BrierleyEJ, JohnsonMA, LightowlersRN, JamesOF, TurnbullDM. Role of mitochondrial DNA mutations in human aging: Implications for the central nervous system and muscle. Ann Neurol, 1998; 43:217–223.
297.
BuaE, JohnsonJ, HerbstA, DelongB, McKenzieD, SalamatS, AikenJM. Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers. Am J Hum Genet, 2006; 79:469–480.
298.
BuaEA, McKiernanSH, WanagatJ, McKenzieD, AikenJM. Mitochondrial abnormalities are more frequent in muscles undergoing sarcopenia. J Appl Physiol, 2002; 92:2617–2624.
299.
TarnopolskyMA. Mitochondrial DNA shifting in older adults following resistance exercise training. Appl Physiol Nutr Metabolism, 2009; 34:348–354.
300.
GomesAP, PriceNL, LingAJ, MoslehiJJ, MontgomeryMK, RajmanL, WhiteJP, TeodoroJS, WrannCD, HubbardBP, MerckenEM, PalmeiraCM, de CaboR, RoloAP, TurnerN, BellEL, SinclairDA. Declining NAD(+) Induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell, 2013; 155:1624–1638.
301.
HowaldH, HoppelerH, ClaassenH, MathieuO, StraubR. Influences of endurance training on the ultrastructural composition of the different muscle fiber types in humans. Pflugers Arch, 1985; 403:369–376.
BigleyAB, SpielmannG, LaVoyEC, SimpsonRJ. Can exercise-related improvements in immunity influence cancer prevention and prognosis in the elderly?. Maturitas, 2013; 76:51–56.
304.
AlcortaDA, XiongY, PhelpsD, HannonG, BeachD, BarrettJC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA, 1996; 93:13742–13747.
305.
SteinGH, DrullingerLF, SoulardA, DulicV. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol, 1999; 19:2109–2117.
306.
HerbigU, JoblingWA, ChenBP, ChenDJ, SedivyJM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell, 2004; 14:501–513.
Pareja-GaleanoH, Sanchis-GomarF, LuciaA. p16INK4a, NAD, and sestrins: New targets for combating aging-related chronic illness?. J Cell Physiol, 2014; 229:1575–1576.
309.
SongZ, von FiguraG, LiuY, KrausJM, TorriceC, DillonP, Rudolph-WatabeM, JuZ, KestlerHA, SanoffH, Lenhard RudolphK. Lifestyle impacts on the aging-associated expression of biomarkers of DNA damage and telomere dysfunction in human blood. Aging Cell, 2010; 9:607–615.
310.
LiuY, SanoffHK, ChoH, BurdCE, TorriceC, IbrahimJG, ThomasNE, SharplessNE. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell, 2009; 8:439–448.
311.
Perez-ManceraPA, YoungAR, NaritaM. Inside and out: The activities of senescence in cancer. Nat Rev Cancer, 2014; 14:547–558.
312.
CoppeJP, DesprezPY, KrtolicaA, CampisiJ. The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu Rev Pathol, 2010; 5:99–118.
313.
van DeursenJM. The role of senescent cells in ageing. Nature, 2014; 509:439–446.
TchkoniaT, ZhuY, van DeursenJ, CampisiJ, KirklandJL. Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities. J Clin Invest, 2013; 123:966–972.
316.
HuangCC, ChiangWD, HuangWC, HuangCY, HsuMC, LinWT. Hepatoprotective effects of swimming exercise against D-galactose-induced senescence rat model. Evid Based Complement Alternat Med, 2013; 2013:275431.
317.
XiaWH, LiJ, SuC, YangZ, ChenL, WuF, ZhangYY, YuBB, QiuYX, WangSM, TaoJ. Physical exercise attenuates age-associated reduction in endothelium-reparative capacity of endothelial progenitor cells by increasing CXCR4/JAK-2 signaling in healthy men. Aging Cell, 2012; 11:111–119.
318.
VerdijkLB, SnijdersT, DrostM, DelhaasT, KadiF, van LoonLJ. Satellite cells in human skeletal muscle; from birth to old age. Age (Dordr), 2014; 36:545–547.
319.
JangYC, SinhaM, CerlettiM, Dall'OssoC, WagersAJ. Skeletal muscle stem cells: Effects of aging and metabolism on muscle regenerative function. Cold Spring Harb Symp Quant Biol, 2011; 76:101–111.
320.
RenaultV, ThornellLE, ErikssonPO, Butler-BrowneG, MoulyV. Regenerative potential of human skeletal muscle during aging. Aging Cell, 2002; 1:132–139.
321.
GopinathSD, RandoTA. Stem cell review series: Aging of the skeletal muscle stem cell niche. Aging Cell, 2008; 7:590–598.
322.
VerdijkLB, SnijdersT, BeelenM, SavelbergHH, MeijerK, KuipersH, Van LoonLJ. Characteristics of muscle fiber type are predictive of skeletal muscle mass and strength in elderly men. J Am Geriatr Soc, 2010; 58:2069–2075.
323.
SheferG, RaunerG, Yablonka-ReuveniZ, BenayahuD. Reduced satellite cell numbers and myogenic capacity in aging can be alleviated by endurance exercise. PLoS One, 2010; 5:e13307.
324.
SheferG, RaunerG, StuelsatzP, BenayahuD, Yablonka-ReuveniZ. Moderate-intensity treadmill running promotes expansion of the satellite cell pool in young and old mice. FEBS J, 2013; 280:4063–4073.
GrubbA, JoanisseS, MooreDR, BellamyLM, MitchellCJ, PhillipsSM, PariseG. IGF-1 colocalizes with muscle satellite cells following acute exercise in humans. Appl Physiol Nutr Metab, 2014; 39:514–518.
328.
McKayBR, OgbornDI, BakerJM, TothKG, TarnopolskyMA, PariseG. Elevated SOCS3 and altered IL-6 signaling is associated with age-related human muscle stem cell dysfunction. Am J Physiol Cell Physiol, 2013; 304:C717–C728.
329.
CermakNM, SnijdersT, McKayBR, PariseG, VerdijkLB, TarnopolskyMA, GibalaMJ, Van LoonLJ. Eccentric exercise increases satellite cell content in type II muscle fibers. Med Sci Sports Exerc, 2013; 45:230–237.
330.
VerdijkLB, GleesonBG, JonkersRA, MeijerK, SavelbergHH, DendaleP, van LoonLJ. Skeletal muscle hypertrophy following resistance training is accompanied by a fiber type-specific increase in satellite cell content in elderly men. J Gerontol A Biol Sci Med Sci, 2009; 64:332–339.
331.
LeendersM, VerdijkLB, van der HoevenL, van KranenburgJ, NilwikR, van LoonLJ. Elderly men and women benefit equally from prolonged resistance-type exercise training. J Gerontol A Biol Sci Med Sci, 2013; 68:769–779.
332.
SnijdersT, VerdijkLB, SmeetsJS, McKayBR, SendenJM, HartgensF, PariseG, GreenhaffP, van LoonLJ. The skeletal muscle satellite cell response to a single bout of resistance-type exercise is delayed with aging in men. Age (Dordr), 2014; 36:9699.
333.
McKayBR, OgbornDI, BellamyLM, TarnopolskyMA, PariseG. Myostatin is associated with age-related human muscle stem cell dysfunction. FASEB J, 2012; 26:2509–2521.
334.
BellamyLM, JoanisseS, GrubbA, MitchellCJ, McKayBR, PhillipsSM, BakerS, PariseG. The acute satellite cell response and skeletal muscle hypertrophy following resistance training. PLoS One, 2014; 9:e109739.
335.
SalminenA, KaarnirantaK, KauppinenA. Inflammaging: Disturbed interplay between autophagy and inflammasomes. Aging (Albany NY), 2012; 4:166–175.
336.
GreenDR, GalluzziL, KroemerG. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science, 2011; 333:1109–1112.
PontAR, SadriN, HsiaoSJ, SmithS, SchneiderRJ. mRNA decay factor AUF1 maintains normal aging, telomere maintenance, and suppression of senescence by activation of telomerase transcription. Mol Cell, 2012; 47:5–15.
339.
LaiRY, LjubicicV, D'SouzaD, HoodDA. Effect of chronic contractile activity on mRNA stability in skeletal muscle. Am J Physiol Cell Physiol, 2010; 299:C155–C163.
340.
NelsonG, WordsworthJ, WangC, JurkD, LawlessC, Martin-RuizC, von ZglinickiT. A senescent cell bystander effect: Senescence-induced senescence. Aging Cell, 2012; 11:345–349.
341.
PedersenBK. Muscular interleukin-6 and its role as an energy sensor. Med Sci Sports Exerc, 2012; 44:392–396.
342.
OstrowskiK, SchjerlingP, PedersenBK. Physical activity and plasma interleukin-6 in humans—effect of intensity of exercise. Eur J Appl Physiol, 2000; 83:512–515.
343.
FischerCP. Interleukin-6 in acute exercise and training: What is the biological relevance?. Exerc Immunol Rev, 2006; 12:6–33.
344.
PedersenBK, FebbraioMA. Muscle as an endocrine organ: Focus on muscle-derived interleukin-6. Physiol Rev, 2008; 88:1379–1406.
345.
PedersenBK. Muscle as a secretory organ. Compr Physiol, 2013; 3:1337–1362.
346.
Della GattaPA, GarnhamAP, PeakeJM, Cameron-SmithD. Effect of exercise training on skeletal muscle cytokine expression in the elderly. Brain Behav Immun, 2014; 39:80–86.
347.
MikkelsenUR, CouppeC, KarlsenA, GrossetJF, SchjerlingP, MackeyAL, KlausenHH, MagnussonSP, KjaerM. Life-long endurance exercise in humans: Circulating levels of inflammatory markers and leg muscle size. Mech Ageing Dev, 2013; 134:531–540.
348.
NicklasBJ, BrinkleyTE. Exercise training as a treatment for chronic inflammation in the elderly. Exerc Sport Sci Rev, 2009; 37:165–170.
349.
BeaversKM, BrinkleyTE, NicklasBJ. Effect of exercise training on chronic inflammation. Clin Chim Acta, 2010; 411:785–793.
350.
ColbertLH, VisserM, SimonsickEM, TracyRP, NewmanAB, KritchevskySB, PahorM, TaaffeDR, BrachJ, RubinS, HarrisTB. Physical activity, exercise, and inflammatory markers in older adults: Findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc, 2004; 52:1098–1104.
MooreSC, PatelAV, MatthewsCE, Berrington de GonzalezA, ParkY, KatkiHA, LinetMS, WeiderpassE, VisvanathanK, HelzlsouerKJ, ThunM, GapsturSM, HartgeP, LeeIM. Leisure time physical activity of moderate to vigorous intensity and mortality: A large pooled cohort analysis. PLoS Med, 2012; 9:e1001335.
353.
GaratacheaN, Santos-LozanoA, Sanchis-GomarF, Fiuza-LucesC, Pareja-GaleanoH, EmanueleE, LucíaA. Elite athletes live longer than the general population: A meta-analysis. Mayo Clin Proc, 2014; 89:1195–1200.
354.
LeeIM, ShiromaEJ, LobeloF, PuskaP, BlairSN, KatzmarzykPT. Effect of physical inactivity on major non-communicable diseases worldwide: An analysis of burden of disease and life expectancy. Lancet, 2012; 380:219–229.
355.
JoynerMJ. Why physiology matters in medicine. Physiology (Bethesda), 2011; 26:72–75.
356.
BinderEF, BrownM, SinacoreDR, Steger-MayK, YarasheskiKE, SchechtmanKB. Effects of extended outpatient rehabilitation after hip fracture: A randomized controlled trial. JAMA, 2004; 292:837–846.
357.
BruunsgaardH, BjerregaardE, SchrollM, PedersenBK. Muscle strength after resistance training is inversely correlated with baseline levels of soluble tumor necrosis factor receptors in the oldest old. J Am Geriatr Soc, 2004; 52:237–241.
358.
CadoreEL, Casas-HerreroA, Zambom-FerraresiF, IdoateF, MillorN, GomezM, Rodriguez-ManasL, IzquierdoM. Multicomponent exercises including muscle power training enhance muscle mass, power output, and functional outcomes in institutionalized frail nonagenarians. Age, 2014; 36:773–785.
359.
ClemsonL, Fiatarone SinghMA, BundyA, CummingRG, ManollarasK, O'LoughlinP, BlackD. Integration of balance and strength training into daily life activity to reduce rate of falls in older people (the LiFE study): Randomised parallel trial. BMJ, 2012; 345:e4547.
360.
DornerT, KranzA, Zettl-WiednerK, LudwigC, RiederA, GisingerC. The effect of structured strength and balance training on cognitive function in frail, cognitive impaired elderly long-term care residents. Aging Clin Exp Res, 2007; 19:400–405.
361.
FiataroneMA, O'NeillEF, RyanND, ClementsKM, SolaresGR, NelsonME, RobertsSB, KehayiasJJ, LipsitzLA, EvansWJ. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med, 1994; 330:1769–1775.
362.
HagedornDK, HolmE. Effects of traditional physical training and visual computer feedback training in frail elderly patients. A randomized intervention study. Eur J Phys Rehab Medi, 2010; 46:159–168.
363.
HauerK, RostB, RutschleK, OpitzH, SpechtN, BartschP, OsterP, SchlierfG. Exercise training for rehabilitation and secondary prevention of falls in geriatric patients with a history of injurious falls. J Am Geriatr Soc, 2001; 49:10–20.
364.
HauerK, SchwenkM, ZieschangT, EssigM, BeckerC, OsterP. Physical training improves motor performance in people with dementia: A randomized controlled trial. J Am Geriatr Soc, 2012; 60:8–15.
365.
KrygerAI, AndersenJL. Resistance training in the oldest old: Consequences for muscle strength, fiber types, fiber size, and MHC isoforms. Scand J Med Sci Sports, 2007; 17:422–430.
366.
LazowskiDA, EcclestoneNA, MyersAM, PatersonDH, Tudor-LockeC, FitzgeraldC, JonesG, ShimaN, CunninghamDA. A randomized outcome evaluation of group exercise programs in long-term care institutions. J Gerontol A Biol Sci Medical Sci, 1999; 54:M621–M628.
367.
MacRaePG, AsplundLA, SchnelleJF, OuslanderJG, AbrahamseA, MorrisC. A walking program for nursing home residents: Effects on walk endurance, physical activity, mobility, and quality of life. J Am Geriatr Soc, 1996; 44:175–180.
368.
McMurdoME, RennieLM. Improvements in quadriceps strength with regular seated exercise in the institutionalized elderly. Arch Phys Med Rehab, 1994; 75:600–603.
369.
McMurdoME, JohnstoneR. A randomized controlled trial of a home exercise programme for elderly people with poor mobility. Age Ageing, 1995; 24:425–428.
370.
PollockRD, MartinFC, NewhamDJ. Whole-body vibration in addition to strength and balance exercise for falls-related functional mobility of frail older adults: A single-blind randomized controlled trial. Clin Rehab, 2012; 26:915–923.
371.
SchnelleJF, AlessiCA, SimmonsSF, Al-SamarraiNR, BeckJC, OuslanderJG. Translating clinical research into practice: A randomized controlled trial of exercise and incontinence care with nursing home residents. J Am Geriatr Soc, 2002; 50:1476–1483.
372.
TimonenL, RantanenT, MakinenE, TimonenTE, TormakangasT, SulkavaR. Effects of a group-based exercise program on functional abilities in frail older women after hospital discharge. Aging Clin Exp Res, 2006; 18:50–56.
373.
BakerLD, FrankLL, Foster-SchubertK, GreenPS, WilkinsonCW, McTiernanA, CholertonBA, PlymateSR, FishelMA, WatsonGS, DuncanGE, MehtaPD, CraftS. Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease. J Alzheimers Dis, 2010; 22:569–579.
374.
BakerLD, CrossDJ, MinoshimaS, BelongiaD, WatsonGS, CraftS. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol, 2011; 68:51–57.
375.
BeckEB, ErbsS, Mobius-WinklerS, AdamsV, WoitekFJ, WaltherT, HambrechtR, MohrFW, StumvollM, BluherM, SchulerG, LinkeA. Exercise training restores the endothelial response to vascular growth factors in patients with stable coronary artery disease. Eur J Prev Cardiol, 2012; 19:412–418.
376.
CassilhasRC, VianaVA, GrassmannV, SantosRT, SantosRF, TufikS, MelloMT. The impact of resistance exercise on the cognitive function of the elderly. Med Sci Sports Exerc, 2007; 39:1401–1407.
EricksonKI, VossMW, PrakashRS, BasakC, SzaboA, ChaddockL, KimJS, HeoS, AlvesH, WhiteSM, WojcickiTR, MaileyE, VieiraVJ, MartinSA, PenceBD, WoodsJA, McAuleyE, KramerAF. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA, 2011; 108:3017–3022.
379.
OgawaK, SanadaK, MachidaS, OkutsuM, SuzukiK. Resistance exercise training-induced muscle hypertrophy was associated with reduction of inflammatory markers in elderly women. Mediators Inflamm, 2010; 2010:171023.
380.
ParkJ, NakamuraY, KwonY, ParkH, KimE, ParkS. The effect of combined exercise training on carotid artery structure and function and vascular endothelial growth factor VEGF in obese older women. Japanese J Phys Fitness Sports Med, 2010; 59:495–504.
381.
PereiraDS, de QueirozBZ, MirandaAS, RochaNP, FelicioDC, MateoEC, FaveroM, CoelhoFM, Jesus-MoraleidaF, Gomes PereiraDA, TeixeiraAL, Maximo PereiraLS. Effects of physical exercise on plasma levels of brain-derived neurotrophic factor and depressive symptoms in elderly women—a randomized clinical trial. Arch Phys Med Rehabil, 2013; 94:1443–1450.
382.
RuizJR, Gil-BeaF, Bustamante-AraN, Rodríguez-RomoG, Fiuza-LucesC, Serra-RexachJA, Cedazo-MinguezA, LuciaA. Resistance training does not have an effect on cognition or related serum biomarkers in nonagenarians: A randomized controlled trial. Int J Sports Med, 2014; 35:1–7.
383.
SchlagerO, GiurgeaA, SchuhfriedO, SeidingerD, HammerA, GrogerM, Fialka-MoserV, GschwandtnerM, KoppensteinerR, SteinerS. Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: A randomized controlled trial. Atherosclerosis, 2011; 217:240–248.
384.
VaughanS, WallisM, PolitD, SteeleM, ShumD, MorrisN. The effects of multimodal exercise on cognitive and physical functioning and brain-derived neurotrophic factor in older women: A randomised controlled trial. Age Ageing, 2014; 43:623–629.
WoodRE, SandersonBE, AskewCD, WalkerPJ, GreenS, StewartIB. Effect of training on the response of plasma vascular endothelial growth factor to exercise in patients with peripheral arterial disease. Clin Sci (Lond), 2006; 111:401–409.
387.
HorsleyV, JansenKM, MillsST, PavlathGK. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell, 2003; 113:483–494.
388.
LafreniereJF, MillsP, BouchentoufM, TremblayJP. Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp Cell Res, 2006; 312:1127–1141.
389.
JacqueminV, Butler-BrowneGS, FurlingD, MoulyV. IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes. J Cell Sci, 2007; 120:670–681.
390.
Al-ShantiN, SainiA, FaulknerSH, StewartCE. Beneficial synergistic interactions of TNF-alpha and IL-6 in C2 skeletal myoblasts—potential cross-talk with IGF system. Growth Factors, 2008; 26:61–73.
391.
CareyAL, SteinbergGR, MacaulaySL, ThomasWG, HolmesAG, RammG, PrelovsekO, Hohnen-BehrensC, WattMJ, JamesDE, KempBE, PedersenBK, FebbraioMA. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes, 2006; 55:2688–2697.
392.
van HallG, SteensbergA, SacchettiM, FischerC, KellerC, SchjerlingP, HiscockN, MollerK, SaltinB, FebbraioMA, PedersenBK. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab, 2003; 88:3005–3010.
393.
SerranoAL, Baeza-RajaB, PerdigueroE, JardiM, Munoz-CanovesP. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab, 2008; 7:33–44.
394.
NielsenAR, HojmanP, ErikstrupC, FischerCP, PlomgaardP, MounierR, MortensenOH, BroholmC, TaudorfS, Krogh-MadsenR, LindegaardB, PetersenAM, GehlJ, PedersenBK. Association between interleukin-15 and obesity: Interleukin-15 as a potential regulator of fat mass. J Clin Endocrinol Metab, 2008; 93:4486–4493.
395.
QuinnLS, AndersonBG. Interleukin-15, IL-15 receptor-alpha, and obesity: Concordance of laboratory animal and human genetic studies. J Obes, 2011; 2011:456347.
QuinnLS, Strait-BodeyL, AndersonBG, ArgilesJM, HavelPJ. Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: Evidence for a skeletal muscle-to-fat signaling pathway. Cell Biol Int, 2005; 29:449–457.
398.
BroholmC, LayeMJ, BrandtC, VadalasettyR, PilegaardH, PedersenBK, ScheeleC. LIF is a contraction-induced myokine stimulating human myocyte proliferation. J Appl Physiol, 2011; 111:251–259.
399.
KurekJ, BowerJ, RomanellaM, AustinL. Leukaemia inhibitory factor treatment stimulates muscle regeneration in the mdx mouse. Neurosci Lett, 1996; 212:167–170.
400.
SpangenburgEE, BoothFW. Leukemia inhibitory factor restores the hypertrophic response to increased loading in the LIF(−/−) mouse. Cytokine, 2006; 34:125–130.
401.
WhiteJD, BowerJJ, KurekJB, AustinL. Leukemia inhibitory factor enhances regeneration in skeletal muscles after myoblast transplantation. Muscle Nerve, 2001; 24:695–697.
402.
HittelDS, AxelsonM, SarnaN, ShearerJ, HuffmanKM, KrausWE. Myostatin decreases with aerobic exercise and associates with insulin resistance. Med Sci Sports Exerc, 2010; 42:2023–2029.
403.
PalsgaardJ, BronsC, FriedrichsenM, DominguezH, JensenM, StorgaardH, SpohrC, Torp-PedersenC, BorupR, De MeytsP, VaagA. Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: Differential regulation of insulin signaling pathways. PLoS One, 2009; 4:e6575.
404.
ConstantinD, McCulloughJ, MahajanRP, GreenhaffPL. Novel events in the molecular regulation of muscle mass in critically ill patients. J Physiol, 2011; 589:3883–3895.
405.
YarasheskiKE, BhasinS, Sinha-HikimI, Pak-LoducaJ, Gonzalez-CadavidNF. Serum myostatin-immunoreactive protein is increased in 60–92 year old women and men with muscle wasting. J Nutr Health Aging, 2002; 6:343–348.
406.
McPherronAC, LeeSJ. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest, 2002; 109:595–601.
407.
KoltaiE, SzaboZ, AtalayM, BoldoghI, NaitoH, GotoS, NyakasC, RadakZ. Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats. Mech Ageing Dev, 2010; 131:21–28.
408.
RomachoT, AzcutiaV, Vazquez-BellaM, MatesanzN, CercasE, NevadoJ, CarraroR, Rodriguez-ManasL, Sanchez-FerrerCF, PeiroC. Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity. Diabetologia, 2009; 52:2455–2463.
409.
ChengQ, DongW, QianL, WuJ, PengY. Visfatin inhibits apoptosis of pancreatic beta-cell line, MIN6, via the mitogen-activated protein kinase/phosphoinositide 3-kinase pathway. J Mol Endocrinol, 2011; 47:13–21.
